Geneva Capital Management LLC Vericel Corp Transaction History
Geneva Capital Management LLC
- $5.28 Billion
- Q1 2025
A detailed history of Geneva Capital Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 1,365,744 shares of VCEL stock, worth $56.7 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
1,365,744
Previous 1,099,788
24.18%
Holding current value
$56.7 Million
Previous $60.4 Million
0.91%
% of portfolio
1.15%
Previous 1.06%
Shares
7 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$145 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$120 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$101 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$94.3 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.96B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...